CellabMed Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

CellabMed General Information

Description

Developer of advanced cell and antibody-based therapies designed for the treatment of serious diseases. The company provides end-to-end services, including basic research, target validation, process development, GMP manufacturing, preclinical evaluation, and regulatory support, enabling the biopharmaceutical market to efficiently develop, scale, and validate next-generation therapies through integrated technical capabilities and certified production infrastructure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3rd Floor, 161, Jeongneung-ro, Seongbuk-gu
  • Jeongneung-dong, Mediscience Park Donghwa Bio Center
  • Seoul, 02708
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 3rd Floor, 161, Jeongneung-ro, Seongbuk-gu
  • Jeongneung-dong, Mediscience Park Donghwa Bio Center
  • Seoul, 02708
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CellabMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Sep-2026 Completed Clinical Trials - Phase 2
6. Later Stage VC 01-Jan-2026 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Private Completed Clinical Trials - Phase 2
4. Early Stage VC (Series B) 14-Nov-2021 Completed Clinical Trials - Phase 2
3. Early Stage VC (Series A) 30-Nov-2019 Completed Clinical Trials - Phase 2
2. Seed Round 20-Jun-2019 Completed Clinical Trials - Phase 2
1. Spin-Off 01-May-2019 Completed Startup
To view CellabMed’s complete valuation and funding history, request access »

CellabMed Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CellabMed FAQs

  • When was CellabMed founded?

    CellabMed was founded in 2019.

  • Where is CellabMed headquartered?

    CellabMed is headquartered in Seoul, South Korea.

  • What is the size of CellabMed?

    CellabMed has 10 total employees.

  • What industry is CellabMed in?

    CellabMed’s primary industry is Drug Discovery.

  • Is CellabMed a private or public company?

    CellabMed is a Private company.

  • What is CellabMed’s current revenue?

    The current revenue for CellabMed is .

  • How much funding has CellabMed raised over time?

    CellabMed has raised $28.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process